Avantor (AVTR) Expected to Release Earnings on Wednesday

Avantor (NYSE:AVTR) is expected to announce its Q2 2026 results before the market opens on Wednesday, July 29th. Analysts expect the company to announce earnings of $0.19 per share and revenue of $1.6107 billion for the quarter. Interested persons may review the information on the company’s upcoming Q2 2026 earning overview page for the latest details on the call scheduled for Wednesday, July 29, 2026 at 8:00 AM ET.

Avantor (NYSE:AVTR) last posted its earnings results on Wednesday, April 29th. The company reported $0.17 earnings per share for the quarter, topping the consensus estimate of $0.16 by $0.01. The company had revenue of $1.58 billion for the quarter, compared to analyst estimates of $1.54 billion. Avantor had a negative net margin of 8.42% and a positive return on equity of 9.95%. The business’s revenue for the quarter was up .0% compared to the same quarter last year. During the same period last year, the business posted $0.23 earnings per share. On average, analysts expect Avantor to post $1 EPS for the current fiscal year and $1 EPS for the next fiscal year.

Avantor Trading Up 0.2%

Shares of NYSE AVTR opened at $11.47 on Monday. Avantor has a twelve month low of $7.26 and a twelve month high of $15.93. The stock has a market cap of $7.83 billion, a price-to-earnings ratio of -14.16, a P/E/G ratio of 6.37 and a beta of 0.94. The company has a quick ratio of 1.17, a current ratio of 1.76 and a debt-to-equity ratio of 0.68. The company’s fifty day moving average is $9.71 and its 200-day moving average is $9.40.

Insiders Place Their Bets

In other news, Director Simon Dingemans purchased 25,000 shares of the business’s stock in a transaction dated Friday, May 1st. The shares were bought at an average cost of $8.14 per share, for a total transaction of $203,500.00. Following the completion of the acquisition, the director directly owned 25,000 shares in the company, valued at approximately $203,500. This trade represents a ? increase in their position. The purchase was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, Director Gregory T. Lucier acquired 10,000 shares of Avantor stock in a transaction dated Friday, May 8th. The shares were purchased at an average cost of $8.32 per share, with a total value of $83,200.00. Following the completion of the transaction, the director directly owned 60,000 shares of the company’s stock, valued at $499,200. This trade represents a 20.00% increase in their ownership of the stock. The SEC filing for this purchase provides additional information. 0.28% of the stock is currently owned by corporate insiders.

Institutional Investors Weigh In On Avantor

A number of hedge funds and other institutional investors have recently bought and sold shares of AVTR. Voleon Capital Management LP bought a new position in shares of Avantor during the 3rd quarter worth approximately $130,000. Smartleaf Asset Management LLC boosted its holdings in Avantor by 9,045.5% during the fourth quarter. Smartleaf Asset Management LLC now owns 11,066 shares of the company’s stock worth $127,000 after purchasing an additional 10,945 shares during the last quarter. American Trust acquired a new position in Avantor during the fourth quarter worth $125,000. Headlands Technologies LLC bought a new position in Avantor in the fourth quarter valued at $116,000. Finally, Cerity Partners LLC bought a new position in Avantor in the fourth quarter valued at $115,000. Institutional investors and hedge funds own 95.08% of the company’s stock.

Wall Street Analysts Forecast Growth

Several analysts recently commented on the company. Zacks Research raised Avantor from a “strong sell” rating to a “hold” rating in a research note on Thursday, April 30th. UBS Group set a $8.00 target price on Avantor in a research note on Wednesday, June 24th. Sanford C. Bernstein began coverage on Avantor in a report on Friday, June 26th. They issued a “market perform” rating and a $10.50 price target for the company. Barclays raised their price target on Avantor from $7.00 to $8.00 and gave the stock an “underweight” rating in a research report on Wednesday, June 24th. Finally, Wolfe Research cut Avantor to an “underperform” rating and set a $7.00 price objective on the stock. in a report on Monday, June 1st. Two analysts have rated the stock with a Buy rating, twelve have issued a Hold rating and three have assigned a Sell rating to the company’s stock. According to data from MarketBeat, the stock presently has an average rating of “Reduce” and a consensus target price of $10.62.

Avantor Company Profile

Avantor, Inc (NYSE:AVTR) is a global provider of mission-critical products and services to customers in the biopharma, healthcare, education & government, and advanced technologies & applied materials industries. The company delivers essential solutions that support research, development, production and safety applications. Its product portfolio spans from high-purity chemicals and reagents to biologics and cell culture media, as well as lab equipment, consumables and custom manufacturing services.

Avantor’s offerings are organized across two primary segments.